These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 37211239)

  • 1. The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches.
    Varesi A; Campagnoli LIM; Chirumbolo S; Candiano B; Carrara A; Ricevuti G; Esposito C; Pascale A
    Pharmacol Res; 2023 Jun; 192():106799. PubMed ID: 37211239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Probiotics and Their Metabolites in the Treatment of Depression.
    Jach ME; Serefko A; Szopa A; Sajnaga E; Golczyk H; Santos LS; Borowicz-Reutt K; Sieniawska E
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37049975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics for the treatment of depression and its comorbidities: A systemic review.
    Gao J; Zhao L; Cheng Y; Lei W; Wang Y; Liu X; Zheng N; Shao L; Chen X; Sun Y; Ling Z; Xu W
    Front Cell Infect Microbiol; 2023; 13():1167116. PubMed ID: 37139495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF/CREB signaling pathway contribution in depression pathogenesis: A survey on the non-pharmacological therapeutic opportunities for gut microbiota dysbiosis.
    Matin S; Dadkhah M
    Brain Res Bull; 2024 Feb; 207():110882. PubMed ID: 38244808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
    Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
    Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota manipulation as an epilepsy treatment.
    Iannone LF; Gómez-Eguílaz M; De Caro C
    Neurobiol Dis; 2022 Nov; 174():105897. PubMed ID: 36257595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
    Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
    EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiotic and Probiotic Modulation of the Microbiota-Gut-Brain Axis in Depression.
    Radford-Smith DE; Anthony DC
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Gut Microbiota for Diagnosis and Treatment of Depression.
    Averina OV; Poluektova EU; Zorkina YA; Kovtun AS; Danilenko VN
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders.
    Gupta S; Dinesh S; Sharma S
    Cent Nerv Syst Agents Med Chem; 2024; 24(1):2-21. PubMed ID: 38265387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
    Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication.
    Evrensel A; Tarhan KN
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110138. PubMed ID: 33075447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the microbiota in pharmacology of psychiatric disorders.
    Pascale A; Marchesi N; Govoni S; Barbieri A
    Pharmacol Res; 2020 Jul; 157():104856. PubMed ID: 32389857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gut Microbiota and Autism Spectrum Disorders: An Overview of Correlations and Potential Implications for Therapeutic Interventions].
    Neubauer J; Kaiser A; Hohmann S
    Z Kinder Jugendpsychiatr Psychother; 2024; 52(3):151-165. PubMed ID: 38098430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Microbiota-Gut-Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect.
    Zhu F; Tu H; Chen T
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.